An interventional study of One cortisone injection and Two cortisone Injections in Stenosing Tenosynovitis and Trigger Finger, sponsored by Rothman Institute Orthopaedics. Status unknown at 7 sites in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2014-02-12.
Sponsored by Rothman Institute Orthopaedics · Not applicable, Interventional, and Treatment
Among 35 studies in Trigger Finger Disorder with a site in United States — 6 open to participants now, 6 under way, none of them phase 3. Trigger Finger Disorder · United States.
Among the 35 studies in Trigger Finger Disorder with a site in United States, this one is the 2nd largest by planned enrollment of the 30 interventional ones, is the only one that started in 2009, is one of 18 with no phase, and was the 1st registered.
93 studies on the registry are indexed under Trigger Finger Disorder; 22 are open to participants now.
This study's planned enrollment of 392 is above the median of 66 across 75 interventional studies indexed under Trigger Finger Disorder.
Browse Trigger Finger Disorder studies →6 of the 35 studies in Trigger Finger Disorder with a site in United States are open now, in 1 country. Each count lists the studies.
Of the 11 Trigger Finger Disorder studies recruiting now, 7 (64%) set no upper age limit and 3 (27%) stop at 75 or younger; 0 take children under 18; 1 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →35 studies; the count open now beside each. This study's row is marked.
First in 2009; this study’s year is marked. 1 started in 2009.
Median enrollment 88 across the 30 interventional studies, 86 across the 5 observational. Of the 23 that completed or were terminated, 9 (39%) have results posted.
None of the 35 has an industry lead sponsor. The 10 most frequent:
Rothman Institute Orthopaedics is the lead sponsor of 119 studies on the registry; 18 are open to participants now.
Of its 6 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Rothman Institute Orthopaedics has 1 study filed under Trigger Finger Disorder — fewer than ten, so there is no comparison to draw.
4 of the studies in Trigger Finger Disorder with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07227649University of ArizonaNAC-REPAIR for Post-surgical Pain | 2027-01-15 |
| NCT07158892University of Texas at AustinUnderstanding Patient Preferences When Deciding on a Voluntary Musculoskeletal Test | 2027-01-20 |
| NCT07516652Washington University School of MedicineProspective Randomized Trial Comparing Longitudinal vs. Transverse A1 Pulley Release | 2027-04-01 |
| NCT05292339Emory UniversityKetorolac in Upper Extremity Tendinopathy and Arthropathy | 2027-07 |
Among the 35 studies in Trigger Finger Disorder with a site in United States, from their registry updates:
Nothing recorded among them since 2026-09-25.
Trigger finger, also known as stenosing tenosynovitis, is a painful condition that can cause discomfort and disability. Many physicians choose to locally inject cortisone into the infected finger although there is no current consensus as to how many injections are needed to achieve maximum relief. This study will be a prospective, randomized study to compare one versus two injections for the treatment of trigger finger.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Drug: One cortisone injection
Drug: Two cortisone Injections
Patients in this arm will receive one cortisone injection for the treatment of his/her symptoms
Subjects randomized to this treatment will receive two cortisone injections, 4-6 weeks apart
To determine if there is a difference in the incidence of pain, stiffness, clicking or locking at 6 months following final injection
To evaluate treatment response among diabetic patients
To evaluate treatment response between thumbs and fingers
To evaluate treatment response between nodular versus diffuse tenosynovitis
This study is status unknown, as verified in Feb 2014. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Rothman Institute Orthopaedics →